Prime Medicine, Inc. (PRME)
NASDAQ:PRME
Want to see PRME full AI Analyst Report?
Prime Medicine, Inc. (PRME) Ownership Overview
46.79% Insiders
7.27% Mutual Funds
27.60% Other Institutional Investors
11.98% ETFs
6.36% Public Companies and
Individual Investors
The ownership structure of Prime Medicine, Inc. (PRME) stock is a mix of institutional, retail, and individual investors. Approximately 46.85% of the company’s stock is owned by Institutional Investors, 46.79% is owned by Insiders, and 6.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 05, 2025 | xxxxxxxxxxxxx | $4950000 | |
Aug 01, 2025 | xxxxxxxxxxxxx | $9999990 | |
Aug 01, 2025 | xxxxxxxxxxxxx | $9999990 | |
Aug 01, 2025 | xxxxxxxxxxxxx | $9999990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $21738958 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $10451529 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $55732 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,240,945 | Insider | 11.21% | 58,091,512 | |
| 18,502,974 | Insider | 10.24% | 53,103,535 | |
| 18,486,894 | Insider | 10.24% | 53,057,386 | |
| 18,486,894 | Insider | 10.24% | 53,057,386 | |
| 6,246,827 | Institution | 3.46% | 17,928,393 | |
| 5,362,576 | Institution | 2.97% | 15,390,593 | |
| 5,305,679 | Insider | 2.94% | 15,227,299 | |
| 4,870,197 | Institution | 2.70% | 13,977,465 | |
| 4,707,620 | Institution | 2.61% | 13,510,869 | |
| 4,461,938 | Institution | 2.47% | 12,805,762 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,371,049 | Institution | 2.42% | 12,544,911 | |
| 1,518,427 | Institution | 0.84% | 4,357,885 | |
| 1,221,196 | Institution | 0.68% | 3,504,833 | |
| 1,202,611 | Institution | 0.67% | 3,451,494 | |
| 1,107,098 | Institution | 0.61% | 3,177,371 | |
| 783,011 | Institution | 0.43% | 2,247,242 | |
| 575,844 | Institution | 0.32% | 1,652,672 | |
| 462,158 | Institution | 0.26% | 1,326,393 | |
| 331,915 | Institution | 0.18% | 952,596 | |
| 328,512 | Institution | 0.18% | 942,829 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,615,482 | Institution | 2.56% | 13,384,898 | |
| 4,431,516 | Institution | 2.45% | 12,718,451 | |
| 3,120,450 | Institution | 1.73% | 11,077,598 | |
| 2,447,622 | Institution | 1.36% | 7,024,675 | |
| 1,260,348 | Institution | 0.70% | 4,474,235 | |
| 881,733 | Institution | 0.49% | 2,530,574 | |
| 695,308 | Institution | 0.38% | 1,995,534 | |
| 646,870 | Institution | 0.36% | 1,968,192 | |
| 527,260 | Institution | 0.29% | 1,871,773 | |
| 520,931 | Institution | 0.29% | 1,510,700 |
FAQ
Who Owns Prime Medicine, Inc. (PRME)?
According to the latest TipRanks data, approximately 27.60% of the company's stock is held by institutional investors, 46.79% is held by insiders, and 6.36% is held by retail investors.
What percentage of Prime Medicine, Inc. (PRME) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.60% of Prime Medicine, Inc. (PRME) stock is held by institutional investors.
What percentage of Prime Medicine, Inc. (PRME) stock is held by retail investors?
According to the latest TipRanks data, approximately 6.36% of Prime Medicine, Inc. (PRME) stock is held by retail investors.
Who owns the most shares of Prime Medicine, Inc. (PRME)?
David R. Liu owns the most shares of Prime Medicine, Inc. (PRME).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.